Atlas Trials

A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome

Clinical trial NCT01237587 · COMPLETED

Trial details

NCT number
NCT01237587
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Fibromyalgia
Start date
2011-03-01
Primary completion
2017-05-31
Enrollment
184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.